Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome (Q40814372)

24 September 2017

title

Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome (English)

1 reference

24 September 2017

0 references

0 references

Seyberth HW

1

1 reference

24 September 2017

Rascher W

2

1 reference

24 September 2017

Schweer H

3

1 reference

24 September 2017

Kühl PG

4

1 reference

24 September 2017

Mehls O

5

1 reference

24 September 2017

Schärer K

6

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 November 1985

1 reference

The Journal of Pediatrics

24 September 2017

published in

1 reference

24 September 2017

volume

107

1 reference

24 September 2017

issue

5

1 reference

24 September 2017

page(s)

694-701

1 reference

Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Role of prostaglandins in the pathogenesis of Bartter's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Evidence for a prostaglandin-independent defect in chloride reabsorption in the loop of henle as a proximal cause of Bartter's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Improved sample preparation for the quantitative mass spectrometric determination of prostaglandins in biological samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Simultaneous determination of prostanoids in plasma by gas chromatography-negative-ion chemical-ionization mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Urinary prostaglandins. Identification and origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Quantifications of the major urinary metabolite of the E prostaglandins by mass spectrometry: evaluation of the method's application to clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

No evidence for product inhibition of the renin-angiotensinogen reaction in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Introduction of plasma indomethacin level monitoring and evaluation of an effective threshold level in very low birth weight infants with symptomatic patent ductus arteriosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Congenital hypokalemia of probable renal origin. A newly described entity due to an inherited metabolic defect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

A variant of Bartter's syndrome. Bartter's syndrome associated with hydramnios, prematurity, hypercalciuria and nephrocalcinosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Idiopathic hypercalciuria associated with hyperreninemia and high urinary prostaglandin E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Prostacyclin overproduction in Bartter's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Regulation of bone formation (second of two parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Prostaglandins as Mediators of Hypercalcemia Associated with Certain Types of Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Renal handling of water and sodium in infancy and childhood: A study using clearance methods during hypotonic saline diuresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

Transient pseudohypoaldosteronism secondary to obstructive uropathy in infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980395-4

10.1016/S0022-3476(85)80395-4

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference